Dr. Michael Goldman, M.D

NPI: 1912220666
Total Payments
$2,103
2024 Payments
$241.81
Companies
12
Transactions
75
Medicare Patients
926
Medicare Billing
$416,717

Payment Breakdown by Category

Food & Beverage$1,495 (71.1%)
Education$407.73 (19.4%)
Other$200.00 (9.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,495 60 71.1%
Education $407.73 14 19.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $200.00 1 9.5%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $727.28 26 $0 (2024)
OPKO Pharmaceuticals, LLC $504.80 19 $0 (2024)
Vifor Pharma, Inc. $319.95 6 $0 (2024)
Amgen Inc. $186.40 10 $0 (2020)
Mallinckrodt Hospital Products Inc. $121.73 3 $0 (2024)
Novartis Pharmaceuticals Corporation $65.82 2 $0 (2024)
Otsuka America Pharmaceutical, Inc. $41.72 2 $0 (2018)
Relypsa, Inc. $35.25 2 $0 (2019)
Fresenius USA Marketing, Inc. $28.24 2 $0 (2019)
Horizon Therapeutics plc $26.64 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $241.81 11 AstraZeneca Pharmaceuticals LP ($63.61)
2023 $563.04 17 AstraZeneca Pharmaceuticals LP ($238.55)
2022 $288.10 7 AstraZeneca Pharmaceuticals LP ($212.64)
2021 $415.53 10 Vifor Pharma, Inc. ($200.00)
2020 $197.21 9 OPKO Pharmaceuticals, LLC ($104.13)
2019 $244.87 13 OPKO Pharmaceuticals, LLC ($84.09)
2018 $113.46 6 Amgen Inc. ($71.74)
2017 $39.01 2 Amgen Inc. ($39.01)

All Payment Transactions

75 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
11/11/2024 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $24.79 General
Category: Hyperkalemia
11/06/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $33.37 General
10/21/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $30.93 General
Category: IMMUNOLOGY
10/15/2024 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $18.62 General
Category: Hyperkalemia
10/14/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $23.39 General
Category: NEPHROLOGY
06/24/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $14.52 General
Category: Cardiovascular and Metabolism
04/17/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.67 General
Category: Cardiovascular and Metabolism
03/11/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $22.02 General
Category: NEPHROLOGY
02/21/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $25.08 General
Category: DIABETES
02/12/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.71 General
Category: Cardiovascular and Metabolism
02/12/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.71 General
Category: Cardiovascular and Metabolism
12/12/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.48 General
Category: Cardiovascular and Metabolism
11/28/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.92 General
Category: Cardiovascular and Metabolism
10/31/2023 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $21.77 General
Category: NEPHROLOGY
10/30/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.06 General
Category: Cardiovascular and Metabolism
10/24/2023 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $32.45 General
10/19/2023 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $20.12 General
Category: Trauma (Emergency, Injury, Surgery)
06/22/2023 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $22.09 General
Category: NEPHROLOGY
06/22/2023 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $1.13 General
Category: NEPHROLOGY
06/14/2023 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $28.81 General
Category: IMMUNOLOGY
05/26/2023 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Education In-kind items and services $61.99 General
Category: IMMUNOLOGY
05/10/2023 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism
04/27/2023 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $30.80 General
Category: NEPHROLOGY
04/19/2023 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $27.72 General
Category: Hyperkalemia
03/22/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $55.93 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 218 484 $166,072 $76,151
2022 8 181 498 $186,060 $94,606
2021 7 188 560 $230,273 $120,424
2020 10 339 878 $294,637 $125,536
Total Patients
926
Total Services
2,420
Medicare Billing
$416,717
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 23 135 $81,000 $39,407 48.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 55 134 $22,512 $9,605 42.7%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 20 28 $15,456 $7,062 45.7%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 18 56 $13,664 $6,036 44.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 16 28 $5,600 $3,055 54.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 23 25 $8,000 $2,963 37.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 17 18 $8,496 $2,826 33.3%
90935 Hemodialysis procedure with physician evaluation Facility 2023 23 34 $5,644 $2,185 38.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $3,600 $1,846 51.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 11 14 $2,100 $1,167 55.6%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 26 213 $127,800 $70,229 55.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 24 66 $16,104 $6,303 39.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 36 78 $13,488 $4,392 32.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 23 47 $7,050 $3,630 51.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 18 25 $5,000 $2,909 58.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 19 22 $7,040 $2,802 39.8%
90935 Hemodialysis procedure with physician evaluation Facility 2022 22 34 $5,678 $2,295 40.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 13 13 $3,900 $2,047 52.5%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 36 285 $171,000 $95,522 55.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 56 109 $18,344 $7,405 40.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 24 62 $15,159 $6,043 39.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 14 29 $5,800 $3,341 57.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 20 23 $7,360 $2,980 40.5%
90935 Hemodialysis procedure with one physician evaluation Facility 2021 25 39 $6,474 $2,671 41.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 13 13 $6,136 $2,463 40.1%

About Dr. Michael Goldman, M.D

Dr. Michael Goldman, M.D is a Internal Medicine healthcare provider based in Kew Gardens, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2010. The National Provider Identifier (NPI) number assigned to this provider is 1912220666.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Goldman, M.D has received a total of $2,103 in payments from pharmaceutical and medical device companies, with $241.81 received in 2024. These payments were reported across 75 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,495).

As a Medicare-enrolled provider, Goldman has provided services to 926 Medicare beneficiaries, totaling 2,420 services with total Medicare billing of $416,717. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Nephrology
  • Location Kew Gardens, NY
  • Active Since 03/09/2010
  • Last Updated 12/05/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1912220666

Products in Payments

  • RAYALDEE (Drug) $420.71
  • LOKELMA (Drug) $355.28
  • Veltassa (Drug) $355.20
  • FARXIGA (Drug) $353.63
  • Parsabiv (Biological) $148.08
  • ACTHAR (Biological) $121.73
  • Rayaldee (Drug) $84.09
  • JYNARQUE (Drug) $41.72
  • Parsabiv (Drug) $38.32
  • Velphoro (Drug) $28.24
  • KRYSTEXXA (Biological) $26.64
  • JARDIANCE (Drug) $25.08
  • Kcentra (Biological) $20.12
  • BRILINTA (Drug) $18.37

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Kew Gardens